Quantification of fluid volume and distribution in the paediatric colon via Magnetic Resonance Imaging

Goelen, Jan and Alexander, Benoni and Eranga Wijesinghe, Haren and Evans, Emily and Pawar, Gopal and Horniblow, Richard D. and Batchelor, Hannah K. (2021) Quantification of fluid volume and distribution in the paediatric colon via Magnetic Resonance Imaging. Pharmaceutics, 13 (10). 1729. ISSN 1999-4923 (https://doi.org/10.3390/pharmaceutics13101729)

[thumbnail of Goelen-etal-Pharmaceutics-2021-Quantification-of-fluid-volume-and-distribution-in-the-paediatric-colon-via-magnetic-resonance-imaging]
Text. Filename: Goelen_etal_Pharmaceutics_2021_Quantification_of_fluid_volume_and_distribution_in_the_paediatric_colon_via_magnetic_resonance_imaging.pdf
Final Published Version
License: Creative Commons Attribution 4.0 logo

Download (2MB)| Preview


Previous studies have used magnetic resonance imaging (MRI) to quantify the fluid in the stomach and small intestine of children, and the stomach, small intestine and colon of adults. This is the first study to quantify fluid volumes and distribution using MRI in the paediatric colon. MRI datasets from 28 fasted (aged 0–15 years) and 18 fluid-fed (aged 10–16 years) paediatric participants were acquired during routine clinical care. A series of 2D- and 3D-based software protocols were used to measure colonic fluid volume and localisation. The paediatric colon contained a mean volume of 22.5 mL ± 41.3 mL fluid, (range 0–167.5 mL, median volume 0.80 mL) in 15.5 ± 17.5 discreet fluid pockets (median 12). The proportion of the fluid pockets larger than 1 mL was 9.6%, which contributed to 94.5% of the total fluid volume observed. No correlation was detected between all-ages and colonic fluid volume, nor was a difference in colonic fluid volumes observed based on sex, fed state or age group based on ICH-classifications. This study quantified fluid volumes within the paediatric colon, and these data will aid and accelerate the development of biorelevant tools to progress paediatric drug development for colon-targeting formulations.